SCHEMBL7205941

SCHEMBL7205941

C1=C(C2=Cc3ccccc3C2)Cc2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.57
CYP11B2 P19099 3/20 0.57
CYP11B1 P15538 2/20 0.57
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
GPR84 Q9NQS5 1/20 0.42
IP6K1 Q92551 1/20 0.41
IP6K3 Q96PC2 1/20 0.41
TRPA1 O75762 1/20 0.41
CYP19A1 P11511 1/20 0.41
TSHR P16473 1/20 0.41
NISCH Q9Y2I1 1/20 0.40
ACHE P22303 1/20 0.39
CYP1A2 P05177 1/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30664496 1.00 PTGS2 (0.57) PTGS2CYP11B2CYP11B1MAOAMAOB
SCHEMBL29672905 0.87 PTGS2 (0.67) PTGS2CYP11B2CYP11B1MAOAMAOB
SCHEMBL7180542 0.87 PTGS2 (0.67) PTGS2CYP11B2CYP11B1MAOAMAOB
SCHEMBL31608568 0.85 CYP11B2 (0.65) PTGS2CYP11B2CYP11B1MAOAMAOB
SCHEMBL29606538 0.85 PTGS2 (0.65) PTGS2CYP11B2CYP11B1MAOAMAOB
SCHEMBL7172726 0.85 PTGS2 (0.65) PTGS2CYP11B2CYP11B1MAOAMAOB
SCHEMBL319265 0.85 CYP11B2 (0.65) PTGS2CYP11B2CYP11B1MAOAMAOB
SCHEMBL31666281 0.84 CYP11B2 (0.62) PTGS2CYP11B2CYP11B1MAOAMAOB
Hydrochloric Acid SCHEMBL17835934 0.84 PTGS2 (0.62) PTGS2CYP11B2CYP11B1MAOAMAOB
Hydrochloric Acid SCHEMBL29672906 0.84 PTGS2 (0.62) PTGS2CYP11B2CYP11B1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300376-B1 FOR THERAPY TO ACHIEVE SMOOTH MUSCLE RELAXING ACTIVITY AND/OR MAST CELL STABILIZING ACTIVITY AND/OR ANTI-INFLAMMATORY ACTIVITY VENANTIUS LIMITED (IR) 2001-10-09 US claimed
CN-104093749-B Catalyst composition and process for preparing the same 沙特基础工业公司 2018-08-07 CN disclosed
CN-1139573-C Fused isoindolones as inhibitors of protein kinase C ����˹���ʹ�˾ 2004-02-25 CN disclosed
EP-0871612-B1 FUSED ISOINDOLONES AS INHIBITORS OF PROTEIN KINASE C CEPHALON INC (US) 2003-03-12 EP disclosed
CN-1224417-A Fused isoindolones as inhibitors of protein kinase C CEPHALON INC (US) 1999-07-28 CN disclosed
EP-0871612-A1 FUSED ISOINDOLONES AS INHIBITORS OF PROTEIN KINASE C CEPHALON, INC. (US) 1998-10-21 EP disclosed
US-5808060-A Fused isoindolones CEPHALON, INC. (US) 1998-09-15 US disclosed
WO-1997021677-A9 FUSED ISOINDOLONES AS INHIBITORS OF PROTEIN KINASE C 1998-07-23 WO disclosed
WO-1997021677-A1 FUSED ISOINDOLONES AS INHIBITORS OF PROTEIN KINASE C CEPHALON, INCORPORATED (US) 1997-06-19 WO disclosed